Stay updated on XEN1101 in Focal-Onset Seizures Clinical Trial
Sign up to get notified when there's something new on the XEN1101 in Focal-Onset Seizures Clinical Trial page.

Latest updates to the XEN1101 in Focal-Onset Seizures Clinical Trial page
- Check5 days agoChange DetectedThe clinical trial record for the Phase 3 X-TOLE2 study is available, including its design, eligibility criteria, treatment arms, outcomes, study dates, and participating locations. The record also indicates that the study is completed and is no longer recruiting participants.SummaryDifference94%

- Check12 days agoChange DetectedThe ClinicalTrials.gov footer revision changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedA sitewide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The footer revision label changes from v3.7.1 to v3.7.2.SummaryDifference1%

- Check40 days agoChange DetectedThe footer revision changed from v3.7.0 to v3.7.1, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check47 days agoChange DetectedThe study record page now displays a 403 Forbidden error page with a 403 message and a Home button. This indicates access is blocked rather than rendering the study details.SummaryDifference0.5%

- Check54 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the usual study record content and blocking access to trial details.SummaryDifference17%

Stay in the know with updates to XEN1101 in Focal-Onset Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the XEN1101 in Focal-Onset Seizures Clinical Trial page.